Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Helsinki University Hospital (HUS) is the largest healthcare provider and clinical research center in Finland, serving nearly 2 million residents. As a leading European academic medical center, HUS integrates high-quality patient care with advanced medical research, particularly in the fields of genomics, personalized medicine, and oncology. The institution is a primary site for international Phase I-III clinical trials and plays a pivotal role in the FinnGen project, utilizing extensive Finnish health registry data. HUS operates several specialized units, including the Comprehensive Cancer Center, which is OECI-accredited, and maintains robust collaborations with the University of Helsinki and global pharmaceutical companies. The hospital district is known for its high-tech infrastructure, including advanced imaging and a dedicated unit for early-phase clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Central University Hospital.